Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents
The Medicines and Healthcare products Regulatory Agency in the U.K. has granted expanded conditional approval for Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine, Nuvaxovid…
Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have completed a submission to the European Medicines Agency (EMA) for a booster dose of an…
Amarin’s New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes
New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes in patients with cardiovascular disease or diabetes with risk factors.
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
Moderna Inc (NASDAQ: MRNA) has
89bio’s Pegozafermin Data Shows Improved Liver Fat, Glycemic Control
89bio Inc (NASDAQ:ETNB) announced the presentation of data from the ENTRIGUE Phase 2 proof-of-concept trial of pegozafermin in severe hypertriglyceridemia (SHTG)…
Merck’s Buyout Of Seagen Hits Speed Braker Over Price Agreement: Report
Merck & Co Inc (NYSE:MRK) and Seagen Inc (NASDAQ:SGEN) have not been able to agree on a buyout price, Bloomberg reported. The…
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
Citi has increased peak risk-adjusted Eli Lilly And Co's (NYSE: LLY) tirzepatide forecasts (diabetes/ obesity/NASH) to more than $25 billion (previously $15 billion, consensus of around $16 billion).
Medtronic Recalls HeartWare HVAD System Batteries For Electrical Faults
Medtronic Plc (NYSE:MDT) is recalling HeartWare HVAD System batteries because they may experience electrical faults that cause the system to fail…
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018.
Pfizer’s COVID-19 Pill Benefited Only Older Adults, New Israel-Based Study Shows
According to a new observational study published in the New England Journal of Medicine, Pfizer Inc's (NYSE: PFE) COVID-19 treatment, Paxlovid, only worked among patients 65 years of age or older, with